Cargando…

An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma

In clinical practice, the cancer-immunity cycle of an individual patient with hepatocellular carcinoma (HCC) must be described to support the clinical management of cancer. The present study explored the immunograms of patients with liver cancer based on liver RNA sequencing data to visually display...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Ying, Sun, Huaibo, Zhang, Henghui, Wang, Xianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413104/ https://www.ncbi.nlm.nih.gov/pubmed/32850343 http://dx.doi.org/10.3389/fonc.2020.01189

Ejemplares similares

A novel scoring method based on RNA‐Seq immunograms describing individual cancer‐immunity interactions
por: Kobayashi, Yukari, et al.
Publicado: (2020)

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
por: Song, Yipeng, et al.
Publicado: (2021)

Case report: A case of heterogeneity of the antitumor response to immune checkpoint inhibitors in a patient with relapsed hepatocellular carcinoma
por: Bao, Yingying, et al.
Publicado: (2022)

CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma
por: Karan, Dev
Publicado: (2021)

How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?
por: Janelle, Valérie, et al.
Publicado: (2014)

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research
por: Sun, Lejia, et al.
Publicado: (2020)

Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma
por: Luo, Mei, et al.
Publicado: (2021)

Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
por: Shi, Ke, et al.
Publicado: (2023)

Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Yongkang, et al.
Publicado: (2021)

Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis
por: De Re, Valli, et al.
Publicado: (2022)

Editorial: Targeting DNA damage response to enhance antitumor innate immunity in radiotherapy
por: Valvo, Victoria, et al.
Publicado: (2023)

SPARC Negatively Correlates With Prognosis After Transarterial Chemoembolization and Facilitates Proliferation and Metastasis of Hepatocellular Carcinoma via ERK/MMP Signaling Pathways
por: Liu, Yao, et al.
Publicado: (2020)

Antitumor Effect and Immune Response of Nanosecond Pulsed Electric Fields in Pancreatic Cancer
por: Zhao, Jing, et al.
Publicado: (2021)

A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma
por: Yang, Hua, et al.
Publicado: (2021)

Hijacker of the Antitumor Immune Response: Autophagy Is Showing Its Worst Facet
por: Viry, Elodie, et al.
Publicado: (2016)

Immune Checkpoint Blockade in Chinese Patients With Hepatocellular Carcinoma: Characteristics and Particularity
por: Wu, Yaoqiang, et al.
Publicado: (2022)

Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma
por: Zhou, Pengcheng, et al.
Publicado: (2021)

Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization
por: Moawad, Ahmed W., et al.
Publicado: (2020)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Zeng, Tian, et al.
Publicado: (2021)

Corrigendum: Antitumor effect and immune response of nanosecond pulsed electric fields in pancreatic cancer
por: Zhao, Jing, et al.
Publicado: (2022)

Case report: Prompt response to radiotherapy and chemotherapy combined with crizotinib in gingival sarcomatoid squamous cell carcinoma with MET 14 mutation
por: Sun, Zhenhua, et al.
Publicado: (2022)

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients
por: Liang, Yuxin, et al.
Publicado: (2022)

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
por: Wan, Gang, et al.
Publicado: (2017)

Sarcopenia and Systemic Inflammation Response Index Predict Response to Systemic Therapy for Hepatocellular Carcinoma and Are Associated With Immune Cells
por: Zhao, Man, et al.
Publicado: (2022)

Fruquintinib Enhances the Antitumor Immune Responses of Anti-Programmed Death Receptor-1 in Colorectal Cancer
por: Li, Qingli, et al.
Publicado: (2022)

A Novel Prognostic Score Based on Artificial Intelligence in Hepatocellular Carcinoma: A Long-Term Follow-Up Analysis
por: Liu, Xiaoli, et al.
Publicado: (2022)

Personal Neoantigens From Patients With NSCLC Induce Efficient Antitumor Responses
por: Zhang, Wei, et al.
Publicado: (2021)

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity
por: Kato, Shumei, et al.
Publicado: (2020)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities
por: Xie, Qingqing, et al.
Publicado: (2022)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
por: Xue, Shen, et al.
Publicado: (2023)

Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis
por: Wen, Kai, et al.
Publicado: (2023)

An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Lin, Zhuo, et al.
Publicado: (2021)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma
por: Shrestha, Ritu, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
por: Guo, Zhanjun, et al.
Publicado: (2022)

In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity
por: Zhang, Bin, et al.
Publicado: (2022)

CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma
por: Cai, Chenhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ugbe1eak0fr1jgm86sn3j4cgqd